Learn how SGLT2 inhibitor dapagliflozin improves MASH outcomes, with potential clinical use beyond diabetes care.

Once considered a niche concern, it is now a growing global epidemic affecting more than one in four adults worldwide.

Once considered a niche concern, it is now a growing global epidemic affecting more than one in four adults worldwide.

Dapagliflozin, a SGLT2 inhibitor used for type 2 diabetes, alleviates steatohepatitis and fibrosis in patients with ...

The spotlight is now on liver health due to the rise of non-alcoholic fatty liver disease, driven by unhealthy lifestyles. Dr ...

Regular screenings combined with a nutrient-dense, balanced diet provide the most effective approach to turning the tide ...

The liver is your body's hardest-working organ. It's the place where everything is processed, and plays a central role in ...

Excess fat mass estimated by waist-circumference-to-height ratio predicts the risk of liver damage better than body mass ...

Belly fat is more than a cosmetic concern—it can signal fatty liver disease. Learn how early diagnosis and lifestyle changes ...

Rising fatty liver cases among youth linked to poor diet, obesity, and sedentary lifestyle. Know causes, risks, and ...

Unlike glucose tests that often fail to spot early imbalances, fasting insulin helps understand the load on the pancreas.

Sedentary lifestyles, unhealthy eating and genetic factors are major reasons for the problem, which needs to be tackled on a ...